Sangamo Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Sangamo Therapeutics (Nasdaq: SGMO) will present a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference on January 13th at 5:20 PM EST. The session will be available for live streaming on the company’s website in the Investors and Media section under Events and Presentations. Sangamo Therapeutics focuses on groundbreaking genomic medicine, utilizing gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing to transform patient lives.
- None.
- None.
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13th at 5:20pm EST.
The virtual session will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will also be available on the Sangamo website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation. For more information about Sangamo, visit www.sangamo.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210105005148/en/
FAQ
When will Sangamo Therapeutics present at the J.P. Morgan Healthcare Conference?
How can I access Sangamo Therapeutics' presentation at the conference?
What is the focus of Sangamo Therapeutics?
What stock symbol represents Sangamo Therapeutics?
